A hybrid continuum–discrete modelling approach to predict and control angiogenesis: analysis of combinatorial growth factor and matrix effects on vessel-sprouting …

A Das, D Lauffenburger, H Asada… - … Transactions of the …, 2010 - royalsocietypublishing.org
Angiogenesis is crucial during many physiological processes and is influenced by various
biochemical and biomechanical factors. Models have proved useful in understanding the …

Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking

WH Tan, AS Popel, F Mac Gabhann - Cellular signalling, 2013 - Elsevier
Abstract Vascular Endothelial Growth Factor (VEGF) signal transduction is central to
angiogenesis in development and in pathological conditions such as cancer, retinopathy …

Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise

JW Ji, F Mac Gabhann… - American Journal of …, 2007 - journals.physiology.org
VEGF is a key promoter of angiogenesis and a major target of proangiogenic therapy for
peripheral arterial disease (PAD). Greater understanding of VEGF angiogenic signaling and …

[HTML][HTML] Multi-physics interactions drive VEGFR2 relocation on endothelial cells

V Damioli, A Salvadori, GP Beretta, C Ravelli… - Scientific reports, 2017 - nature.com
Abstract Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) is a pro-angiogenic
receptor, expressed on endothelial cells (ECs). Although biochemical pathways that follow …

[HTML][HTML] Mathematical model predicts effective strategies to inhibit VEGF-eNOS signaling

Q Wu, SD Finley - Journal of Clinical Medicine, 2020 - mdpi.com
The endothelial nitric oxide synthase (eNOS) signaling pathway in endothelial cells has
multiple physiological significances. It produces nitric oxide (NO), an important vasodilator …

[HTML][HTML] Computational modeling of interacting VEGF and soluble VEGF receptor concentration gradients

YL Hashambhoy, JC Chappell, SM Peirce… - Frontiers in …, 2011 - frontiersin.org
Experimental data indicates that soluble vascular endothelial growth factor (VEGF) receptor
1 (sFlt-1) modulates the guidance cues provided to sprouting blood vessels by VEGF-A. To …

VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model

FTH Wu, MO Stefanini, FM Gabhann… - American Journal …, 2010 - journals.physiology.org
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis, the growth of
new capillaries from existing microvasculature. In peripheral arterial disease (PAD), lower …

Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism …

MB Kuznetsov, AV Kolobov - Journal of theoretical biology, 2018 - Elsevier
A number of experiments on mouse tumor models, as well as certain clinical data, have
demonstrated, that antiangiogenic therapy can lead to transient improvement in tumor …

[HTML][HTML] Negative pressure wound therapy induces early wound healing by increased and accelerated expression of vascular endothelial growth factor receptors

T Tanaka, N Panthee, Y Itoda, N Yamauchi… - European journal of …, 2016 - Springer
Background Negative pressure wound therapy (NPWT) is commonly used to accelerate
wound healing, especially following thoracic surgery; however, the mechanism remains …

[HTML][HTML] A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands

LE Clegg, F Mac Gabhann - PLoS computational biology, 2017 - journals.plos.org
The splice isoforms of vascular endothelial growth A (VEGF) each have different affinities for
the extracellular matrix (ECM) and the coreceptor NRP1, which leads to distinct vascular …